% alzhub.org library filter % Source: https://alzhub.org/research?author=Rosa-Neto+P % 17 entries, in the order the page lists them. Built from alzhub.org's own records. % 0 entries have no readable author in the source record and carry no author field. @article{ossenkoppele2025-40155777, author = {Ossenkoppele, R. and Salvadó, G. and Janelidze, S. and Pichet Binette, A. and Bali, D. and Karlsson, L. and Palmqvist, S. and Mattsson-Carlgren, N. and Stomrud, E. and Therriault, J. and Rahmouni, N. and Rosa-Neto, P. and others}, title = {{Plasma p-tau217 and tau-PET predict future cognitive decline among cognitively unimpaired individuals: implications for clinical trials}}, journal = {Nature Aging}, year = {2025}, doi = {10.1038/s43587-025-00835-z}, pmid = {40155777}, url = {https://doi.org/10.1038/s43587-025-00835-z} } @article{bellaver2021-33952650, author = {Bellaver, B. and Ferrari-Souza, J. P. and Uglione da Ros, L. and Carter, S. F. and Rodriguez-Vieitez, E. and Nordberg, A. and Pellerin, L. and Rosa-Neto, P. and others}, title = {{Astrocyte Biomarkers in Alzheimer Disease: A Systematic Review and Meta-analysis}}, journal = {Neurology}, year = {2021}, doi = {10.1212/wnl.0000000000012109}, pmid = {33952650}, url = {https://doi.org/10.1212/wnl.0000000000012109} } @article{meyer2019-30952794, author = {Meyer, P. F. and Tremblay-Mercier, J. and Leoutsakos, J. and Madjar, C. and Lafaille-Magnan, M. E. and Savard, M. and Rosa-Neto, P. and Poirier, J. and others}, title = {{INTREPAD: A randomized trial of naproxen to slow progress of presymptomatic Alzheimer disease}}, journal = {Neurology}, year = {2019}, doi = {10.1212/wnl.0000000000007232}, pmid = {30952794}, url = {https://doi.org/10.1212/wnl.0000000000007232} } @article{yakoub2025-40008832, author = {Yakoub, Y. and Gonzalez-Ortiz, F. and Ashton, N. J. and Déry, C. and Strikwerda-Brown, C. and St-Onge, F. and Ourry, V. and Schöll, M. and Geddes, M. R. and Ducharme, S. and Montembeault, M. and Rosa-Neto, P. and others}, title = {{Plasma p-tau217 identifies cognitively normal older adults who will develop cognitive impairment in a 10-year window}}, journal = {Alzheimer's \& Dementia}, year = {2025}, doi = {10.1002/alz.14537}, pmid = {40008832}, url = {https://doi.org/10.1002/alz.14537} } @article{lafaillemagnan2017-28659431, author = {Lafaille-Magnan, M. E. and Poirier, J. and Etienne, P. and Tremblay-Mercier, J. and Frenette, J. and Rosa-Neto, P. and Breitner, J. C. S. and {PREVENT-AD Research Group}}, title = {{Odor identification as a biomarker of preclinical AD in older adults at risk}}, journal = {Neurology}, year = {2017}, doi = {10.1212/wnl.0000000000004159}, pmid = {28659431}, url = {https://doi.org/10.1212/wnl.0000000000004159} } @article{iturriamedina2022-36399579, author = {Iturria-Medina, Y. and Adewale, Q. and Khan, A. F. and Ducharme, S. and Rosa-Neto, P. and O'Donnell, K. and Petyuk, V. A. and Gauthier, S. and others}, title = {{Unified epigenomic, transcriptomic, proteomic, and metabolomic taxonomy of Alzheimer's disease progression and heterogeneity}}, journal = {Science advances}, year = {2022}, doi = {10.1126/sciadv.abo6764}, pmid = {36399579}, url = {https://doi.org/10.1126/sciadv.abo6764} } @article{zhang2018-30311914, author = {Zhang, H. and Ng, K. P. and Therriault, J. and Kang, M. S. and Pascoal, T. A. and Rosa-Neto, P. and Gauthier, S. and {Alzheimer’s Disease Neuroimaging Initiative}}, title = {{Cerebrospinal fluid phosphorylated tau, visinin-like protein-1, and chitinase-3-like protein 1 in mild cognitive impairment and Alzheimer's disease}}, journal = {Translational neurodegeneration}, year = {2018}, doi = {10.1186/s40035-018-0127-7}, pmid = {30311914}, url = {https://doi.org/10.1186/s40035-018-0127-7} } @article{meyer2018-29660934, author = {Meyer, P. F. and Savard, M. and Poirier, J. and Labonté, A. and Rosa-Neto, P. and Weitz, T. M. and Town, T. and Breitner, J. and others}, title = {{Bi-directional Association of Cerebrospinal Fluid Immune Markers with Stage of Alzheimer's Disease Pathogenesis}}, journal = {Journal of Alzheimer's disease : JAD}, year = {2018}, doi = {10.3233/jad-170887}, pmid = {29660934}, url = {https://doi.org/10.3233/jad-170887} } @article{zhang2018-30115118, author = {Zhang, H. and Therriault, J. and Kang, M. S. and Ng, K. P. and Pascoal, T. A. and Rosa-Neto, P. and Gauthier, S. and {Alzheimer’s Disease Neuroimaging Initiative}}, title = {{Cerebrospinal fluid synaptosomal-associated protein 25 is a key player in synaptic degeneration in mild cognitive impairment and Alzheimer's disease}}, journal = {Alzheimer's research \& therapy}, year = {2018}, doi = {10.1186/s13195-018-0407-6}, pmid = {30115118}, url = {https://doi.org/10.1186/s13195-018-0407-6} } @article{mcsweeney2020-32015176, author = {McSweeney, M. and Pichet Binette, A. and Meyer, P. F. and Gonneaud, J. and Bedetti, C. and Ozlen, H. and Labonté, A. and Rosa-Neto, P. and others}, title = {{Intermediate flortaucipir uptake is associated with Aβ-PET and CSF tau in asymptomatic adults}}, journal = {Neurology}, year = {2020}, doi = {10.1212/wnl.0000000000008905}, pmid = {32015176}, url = {https://doi.org/10.1212/wnl.0000000000008905} } @article{tianhuikwan2020-33321511, author = {Tian Hui Kwan, A. and Arfaie, S. and Therriault, J. and Rosa-Neto, P. and Gauthier, S.}, title = {{Lessons Learnt from the Second Generation of Anti-Amyloid Monoclonal Antibodies Clinical Trials}}, journal = {Dementia and geriatric cognitive disorders}, year = {2020}, doi = {10.1159/000511506}, pmid = {33321511}, url = {https://doi.org/10.1159/000511506} } @article{wang2023-37639461, author = {Wang, Y. T. and Rosa-Neto, P. and Gauthier, S.}, title = {{Advanced brain imaging for the diagnosis of Alzheimer disease}}, journal = {Current opinion in neurology}, year = {2023}, doi = {10.1097/wco.0000000000001198}, pmid = {37639461}, url = {https://doi.org/10.1097/wco.0000000000001198} } @article{laforce2016-26916179, author = {Laforce, R. and Rosa-Neto, P. and Soucy, J. P. and Rabinovici, G. D. and Dubois, B. and Gauthier, S.}, title = {{Canadian Consensus Guidelines on Use of Amyloid Imaging in Canada: Update and Future Directions from the Specialized Task Force on Amyloid imaging in Canada}}, journal = {The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques}, year = {2016}, doi = {10.1017/cjn.2015.401}, pmid = {26916179}, url = {https://doi.org/10.1017/cjn.2015.401} } @article{rosaneto2013-24565514, author = {Rosa-Neto, P. and Hsiung, G. Y. and Masellis, M. and participants, CCDTD4}, title = {{Fluid biomarkers for diagnosing dementia: rationale and the Canadian Consensus on Diagnosis and Treatment of Dementia recommendations for Canadian physicians}}, journal = {Alzheimer's research \& therapy}, year = {2013}, doi = {10.1186/alzrt223}, pmid = {24565514}, url = {https://doi.org/10.1186/alzrt223} } @article{ryu2019-31270743, author = {Ryu, J. C. and Zimmer, E. R. and Rosa-Neto, P. and Yoon, S. O.}, title = {{Consequences of Metabolic Disruption in Alzheimer's Disease Pathology}}, journal = {Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics}, year = {2019}, doi = {10.1007/s13311-019-00755-y}, pmid = {31270743}, url = {https://doi.org/10.1007/s13311-019-00755-y} } @article{carter2019-30611668, author = {Carter, S. F. and Herholz, K. and Rosa-Neto, P. and Pellerin, L. and Nordberg, A. and Zimmer, E. R.}, title = {{Astrocyte Biomarkers in Alzheimer's Disease}}, journal = {Trends in molecular medicine}, year = {2019}, doi = {10.1016/j.molmed.2018.11.006}, pmid = {30611668}, url = {https://doi.org/10.1016/j.molmed.2018.11.006} } @article{ongali2014-24807206, author = {Ongali, B. and Nicolakakis, N. and Tong, X. K. and Aboulkassim, T. and Papadopoulos, P. and Rosa-Neto, P. and Lecrux, C. and Imboden, H. and others}, title = {{Angiotensin II type 1 receptor blocker losartan prevents and rescues cerebrovascular, neuropathological and cognitive deficits in an Alzheimer's disease model}}, journal = {Neurobiology of disease}, year = {2014}, doi = {10.1016/j.nbd.2014.04.018}, pmid = {24807206}, url = {https://doi.org/10.1016/j.nbd.2014.04.018} }